Current Environment: Production

Rachel Rosen | Education

Undergraduate School

Harvard University

1994, Cambridge, MA

Medical School

Dartmouth Medical School

1998, Hanover, NH

Internship

Duke University Medical Center

1999, Durham, MA

Residency

Duke University Medical Center

2001, Durham, NC

Fellowship

Boston Children's Hospital

2004, Boston, MA

Rachel Rosen | Certifications

  • American Board of Pediatrics (Gastroenterology)

Rachel Rosen | Media

Caregiver Profile

Meet Dr. Rachel Rosen

Rachel Rosen | Publications

  1. Outcomes for infants with BRUE diagnosed with oropharyngeal dysphagia or gastroesophageal reflux disease: a multicenter study from the Pediatric Health Information System Database. Eur J Pediatr. 2025 Jan 14; 184(2):134. View Outcomes for infants with BRUE diagnosed with oropharyngeal dysphagia or gastroesophageal reflux disease: a multicenter study from the Pediatric Health Information System Database. Abstract

  2. Prevalence and Trends in Cigarette Smoking With and Without Tobacco Use Disorder Among Adults in the United States: 2010-2021. J Clin Psychiatry. 2024 Jun 12; 85(3). View Prevalence and Trends in Cigarette Smoking With and Without Tobacco Use Disorder Among Adults in the United States: 2010-2021. Abstract

  3. Brief Resolved Unexplained Events Symptoms Frequently Result in Inappropriate Gastrointestinal Diagnoses and Treatment. J Pediatr. 2024 Sep; 272:114128. View Brief Resolved Unexplained Events Symptoms Frequently Result in Inappropriate Gastrointestinal Diagnoses and Treatment. Abstract

  4. Transpyloric feeding is associated with adverse in-hospital outcomes in infants with severe bronchopulmonary dysplasia. J Perinatol. 2024 02; 44(2):307-313. View Transpyloric feeding is associated with adverse in-hospital outcomes in infants with severe bronchopulmonary dysplasia. Abstract

  5. Breastfeeding in infants who aspirate may increase risk of pulmonary inflammation. Pediatr Pulmonol. 2024 Mar; 59(3):600-608. View Breastfeeding in infants who aspirate may increase risk of pulmonary inflammation. Abstract

  6. A Prospective Study of Parental Experience with Thickening Feeds for Children with Oropharyngeal Dysphagia and Gastroesophageal Reflux. J Pediatr. 2023 09; 260:113510. View A Prospective Study of Parental Experience with Thickening Feeds for Children with Oropharyngeal Dysphagia and Gastroesophageal Reflux. Abstract

  7. Gastrointestinal factors associated with risk of bronchiectasis in children. Pediatr Pulmonol. 2023 03; 58(3):899-907. View Gastrointestinal factors associated with risk of bronchiectasis in children. Abstract

  8. A Prospective Study of Brief Resolved Unexplained Events: Risk Factors for Persistent Symptoms. Hosp Pediatr. 2022 12 01; 12(12):1030-1043. View A Prospective Study of Brief Resolved Unexplained Events: Risk Factors for Persistent Symptoms. Abstract

  9. Airway Impedance: A Novel Diagnostic Tool to Predict Extraesophageal Airway Inflammation. J Pediatr. 2023 05; 256:5-10.e2. View Airway Impedance: A Novel Diagnostic Tool to Predict Extraesophageal Airway Inflammation. Abstract

  10. A prospective study of intrapyloric botulinum toxin and EndoFLIP in children with nausea and vomiting. Neurogastroenterol Motil. 2022 Nov; 34(11):e14428. View A prospective study of intrapyloric botulinum toxin and EndoFLIP in children with nausea and vomiting. Abstract

  11. Gastrostomy Tube Use in Pediatrics: A Systematic Review. Pediatrics. 2022 06 01; 149(6). View Gastrostomy Tube Use in Pediatrics: A Systematic Review. Abstract

  12. Low diagnostic yield in BRUE hospitalization. J Pediatr. 2022 05; 244:250-254. View Low diagnostic yield in BRUE hospitalization. Abstract

  13. Pneumatosis intestinalis after thoracic organ transplantation in children: A case series and review of the literature. Clin Transplant. 2022 06; 36(6):e14654. View Pneumatosis intestinalis after thoracic organ transplantation in children: A case series and review of the literature. Abstract

  14. Assessing Sex, Gender Identity, Sexual Orientation, Race, Ethnicity, Socioeconomic Status, and Mental Health Concerns in Tobacco Use Disorder Treatment Research: Measurement Challenges and Recommendations From a Society for Research on Nicotine and Tobacco Pre-conference Workshop. Nicotine Tob Res. 2022 03 26; 24(5):643-653. View Assessing Sex, Gender Identity, Sexual Orientation, Race, Ethnicity, Socioeconomic Status, and Mental Health Concerns in Tobacco Use Disorder Treatment Research: Measurement Challenges and Recommendations From a Society for Research on Nicotine and Tobacco Pre-conference Workshop. Abstract

  15. Effect of Added Free Water to Enteral Tube Feeds in Children Receiving Commercial Blends. J Pediatr Gastroenterol Nutr. 2022 03 01; 74(3):419-423. View Effect of Added Free Water to Enteral Tube Feeds in Children Receiving Commercial Blends. Abstract

  16. International Consensus Recommendations for Eosinophilic Gastrointestinal Disease Nomenclature. Clin Gastroenterol Hepatol. 2022 11; 20(11):2474-2484.e3. View International Consensus Recommendations for Eosinophilic Gastrointestinal Disease Nomenclature. Abstract

  17. The Utility of Functional Luminal Imaging Probes Measurements to Diagnose Dysmotility and Their Relationship to Impaired Bolus Clearance. J Pediatr Gastroenterol Nutr. 2022 04 01; 74(4):523-528. View The Utility of Functional Luminal Imaging Probes Measurements to Diagnose Dysmotility and Their Relationship to Impaired Bolus Clearance. Abstract

  18. Development of a Core Outcome Set for Children Aged 1-18 Years with Gastroesophageal Reflux Disease. J Pediatr. 2022 06; 245:129-134.e5. View Development of a Core Outcome Set for Children Aged 1-18 Years with Gastroesophageal Reflux Disease. Abstract

  19. Prucalopride for Treatment of Upper Gastrointestinal Symptoms in Children. Paediatr Drugs. 2022 Jan; 24(1):73-81. View Prucalopride for Treatment of Upper Gastrointestinal Symptoms in Children. Abstract

  20. Impact of Coronavirus Disease 2019 on the Pediatric Population with Aerodigestive Disease. J Pediatr. 2022 04; 243:14-20.e1. View Impact of Coronavirus Disease 2019 on the Pediatric Population with Aerodigestive Disease. Abstract

  21. Risk Factors for Bile Aspiration and its Impact on Clinical Outcomes. Clin Transl Gastroenterol. 2021 12 07; 12(12):e00434. View Risk Factors for Bile Aspiration and its Impact on Clinical Outcomes. Abstract

  22. Overall Impact of Coronavirus Disease 2019 Outbreak in Children With Functional Abdominal Pain Disorders: Results From the First Pandemic Phase. J Pediatr Gastroenterol Nutr. 2021 12 01; 73(6):689-694. View Overall Impact of Coronavirus Disease 2019 Outbreak in Children With Functional Abdominal Pain Disorders: Results From the First Pandemic Phase. Abstract

  23. A Retrospective Review of Primary Percutaneous Endoscopic Gastrostomy and Laparoscopic Gastrostomy Tube Placement. J Pediatr Gastroenterol Nutr. 2021 Nov 01; 73(5):586-591. View A Retrospective Review of Primary Percutaneous Endoscopic Gastrostomy and Laparoscopic Gastrostomy Tube Placement. Abstract

  24. Evaluating the adherence to national guidelines for treatment of gastroesophageal reflux in infants. Acta Paediatr. 2022 Feb; 111(2):440-441. View Evaluating the adherence to national guidelines for treatment of gastroesophageal reflux in infants. Abstract

  25. Factors associated with past-year attempts to quit e-cigarettes among current users: Findings from the Population Assessment of Tobacco and Health Wave 4 (2017-2018). Drug Alcohol Depend. 2021 10 01; 227:108973. View Factors associated with past-year attempts to quit e-cigarettes among current users: Findings from the Population Assessment of Tobacco and Health Wave 4 (2017-2018). Abstract

  26. Risk of aspiration pneumonia in paediatric patients with dysphagia who were found to have laryngeal penetration on the instrumental swallow evaluation: a systematic review protocol. BMJ Open. 2021 08 03; 11(8):e048422. View Risk of aspiration pneumonia in paediatric patients with dysphagia who were found to have laryngeal penetration on the instrumental swallow evaluation: a systematic review protocol. Abstract

  27. Pharmacogenomics fail to explain proton pump inhibitor refractory esophagitis in pediatric esophageal atresia. Neurogastroenterol Motil. 2022 01; 34(1):e14217. View Pharmacogenomics fail to explain proton pump inhibitor refractory esophagitis in pediatric esophageal atresia. Abstract

  28. PedsQL™ Gastroparesis Symptoms Module Domain and Item Development: Qualitative Methods. J Pediatr Gastroenterol Nutr. 2021 08 01; 73(2):192-196. View PedsQL™ Gastroparesis Symptoms Module Domain and Item Development: Qualitative Methods. Abstract

  29. Gastro-oesophageal reflux disease. Nat Rev Dis Primers. 2021 07 29; 7(1):55. View Gastro-oesophageal reflux disease. Abstract

  30. Response to Febo-Rodriguez et al. Am J Gastroenterol. 2021 07 01; 116(7):1553. View Response to Febo-Rodriguez et al. Abstract

  31. Acid Suppression Does Not Improve Laryngomalacia Outcomes but Treatment for Oropharyngeal Dysphagia Might Be Protective. J Pediatr. 2021 Nov; 238:42-49.e2. View Acid Suppression Does Not Improve Laryngomalacia Outcomes but Treatment for Oropharyngeal Dysphagia Might Be Protective. Abstract

  32. Metabolomic profiling of extraesophageal reflux disease in children. Clin Transl Sci. 2021 09; 14(5):2025-2033. View Metabolomic profiling of extraesophageal reflux disease in children. Abstract

  33. Overlapping Symptoms of Gastroesophageal Reflux and Aspiration Highlight the Limitations of Validated Questionnaires. J Pediatr Gastroenterol Nutr. 2021 03 01; 72(3):372-377. View Overlapping Symptoms of Gastroesophageal Reflux and Aspiration Highlight the Limitations of Validated Questionnaires. Abstract

  34. Clinician Knowledge of Societal Guidelines on Management of Gastrointestinal Complications in Esophageal Atresia. J Pediatr Gastroenterol Nutr. 2021 02 01; 72(2):232-238. View Clinician Knowledge of Societal Guidelines on Management of Gastrointestinal Complications in Esophageal Atresia. Abstract

  35. Development of Entrustable Professional Activities and Standards in Training in Pediatric Neurogastroenterology and Motility: North American Society for Pediatric Gastroenterology, Hepatology and Nutrition and American Neurogastroenterology and Motility Society Position Paper. J Pediatr Gastroenterol Nutr. 2021 01 01; 72(1):168-180. View Development of Entrustable Professional Activities and Standards in Training in Pediatric Neurogastroenterology and Motility: North American Society for Pediatric Gastroenterology, Hepatology and Nutrition and American Neurogastroenterology and Motility Society Position Paper. Abstract

  36. Comparison of Aerodigestive and Nonaerodigestive Provider Responses to Clinical Case Vignettes. J Pediatr. 2021 05; 232:166-175.e2. View Comparison of Aerodigestive and Nonaerodigestive Provider Responses to Clinical Case Vignettes. Abstract

  37. The impact of gastrointestinal dysmotility on the aerodigestive microbiome of pediatric lung transplant recipients. J Heart Lung Transplant. 2021 03; 40(3):210-219. View The impact of gastrointestinal dysmotility on the aerodigestive microbiome of pediatric lung transplant recipients. Abstract

  38. The Ethics of Feeding the Aspirating Child in an Age of Increasing Patient Complexity. J Pediatr Gastroenterol Nutr. 2020 11; 71(5):586-588. View The Ethics of Feeding the Aspirating Child in an Age of Increasing Patient Complexity. Abstract

  39. Pediatric Solid Gastric Emptying Scintigraphy: Normative Value Guidelines and Nonstandard Meal Alternatives. Am J Gastroenterol. 2020 11; 115(11):1830-1839. View Pediatric Solid Gastric Emptying Scintigraphy: Normative Value Guidelines and Nonstandard Meal Alternatives. Abstract

  40. Prevalence of Feeding Disorders: A Tough Reality to Swallow. J Pediatr. 2021 01; 228:13-14. View Prevalence of Feeding Disorders: A Tough Reality to Swallow. Abstract

  41. A Pilot Randomized Clinical Trial of Brief Interventions to Encourage Quit Attempts in Smokers From Socioeconomic Disadvantage. Nicotine Tob Res. 2020 08 24; 22(9):1500-1508. View A Pilot Randomized Clinical Trial of Brief Interventions to Encourage Quit Attempts in Smokers From Socioeconomic Disadvantage. Abstract

  42. Proceedings of the 2018 Advances In Motility and In NeuroGastroenterology: AIMING for the Future Single Topic Symposium. J Pediatr Gastroenterol Nutr. 2020 08; 71(2):e59-e67. View Proceedings of the 2018 Advances In Motility and In NeuroGastroenterology: AIMING for the Future Single Topic Symposium. Abstract

  43. GOT MILK-ish? J Pediatr Gastroenterol Nutr. 2020 08; 71(2):149. View GOT MILK-ish? Abstract

  44. Botulinum Toxin as a Treatment for Feeding Difficulties in Young Children. J Pediatr. 2020 11; 226:228-235. View Botulinum Toxin as a Treatment for Feeding Difficulties in Young Children. Abstract

  45. Functional Luminal Imaging Probe Assessment in Postfundoplication Patients Changes Management Beyond Manometry. J Pediatr Gastroenterol Nutr. 2020 06; 70(6):e119-e123. View Functional Luminal Imaging Probe Assessment in Postfundoplication Patients Changes Management Beyond Manometry. Abstract

  46. Viscosity of Commercial Food-based Formulas and Home-prepared Blenderized Feeds. J Pediatr Gastroenterol Nutr. 2020 06; 70(6):e124-e128. View Viscosity of Commercial Food-based Formulas and Home-prepared Blenderized Feeds. Abstract

  47. Adherence to low-calorie and low-sugar diets is uniquely associated with distinct facets of appearance/weight-related smoking motivations. J Behav Med. 2020 06; 43(3):487-492. View Adherence to low-calorie and low-sugar diets is uniquely associated with distinct facets of appearance/weight-related smoking motivations. Abstract

  48. Omeprazole inhibits IgE-mediated mast cell activation and allergic inflammation induced by ingested allergen in mice. J Allergy Clin Immunol. 2020 10; 146(4):884-893.e5. View Omeprazole inhibits IgE-mediated mast cell activation and allergic inflammation induced by ingested allergen in mice. Abstract

  49. Reply. J Pediatr. 2020 05; 220:268. View Reply. Abstract

  50. A Quality Improvement Initiative to Reduce Gastrostomy Tube Placement in Aspirating Patients. Pediatrics. 2020 02; 145(2). View A Quality Improvement Initiative to Reduce Gastrostomy Tube Placement in Aspirating Patients. Abstract

  51. Abnormal 24-hour pH-impedance Testing Does Not Predict Reduced Quality of Life in Children With Reflux Symptoms. J Pediatr Gastroenterol Nutr. 2020 01; 70(1):31-36. View Abnormal 24-hour pH-impedance Testing Does Not Predict Reduced Quality of Life in Children With Reflux Symptoms. Abstract

  52. Over the Counter Complexities. J Pediatr Gastroenterol Nutr. 2020 01; 70(1):1. View Over the Counter Complexities. Abstract

  53. The Spectrum of Reflux Phenotypes. Gastroenterol Hepatol (N Y). 2019 Dec; 15(12):646-654. View The Spectrum of Reflux Phenotypes. Abstract

  54. Continuous Feedings Are Not Associated With Lower Rates of Gastroesophageal Reflux When Compared With Bolus Feedings. J Pediatr Gastroenterol Nutr. 2019 12; 69(6):678-681. View Continuous Feedings Are Not Associated With Lower Rates of Gastroesophageal Reflux When Compared With Bolus Feedings. Abstract

  55. Pepsin Triggers Neutrophil Migration Across Acid Damaged Lung Epithelium. Sci Rep. 2019 09 24; 9(1):13778. View Pepsin Triggers Neutrophil Migration Across Acid Damaged Lung Epithelium. Abstract

  56. Deepening the Understanding of Functional and Motility Disorders. J Pediatr Gastroenterol Nutr. 2019 06; 68(6):761. View Deepening the Understanding of Functional and Motility Disorders. Abstract

  57. Health Outcomes and Quality of Life Indices of Children Receiving Blenderized Feeds via Enteral Tube. J Pediatr. 2019 08; 211:139-145.e1. View Health Outcomes and Quality of Life Indices of Children Receiving Blenderized Feeds via Enteral Tube. Abstract

  58. Aerodigestive sampling reveals altered microbial exchange between lung, oropharyngeal, and gastric microbiomes in children with impaired swallow function. PLoS One. 2019; 14(5):e0216453. View Aerodigestive sampling reveals altered microbial exchange between lung, oropharyngeal, and gastric microbiomes in children with impaired swallow function. Abstract

  59. Clinical Aspects of Thickeners for Pediatric Gastroesophageal Reflux and Oropharyngeal Dysphagia. Curr Gastroenterol Rep. 2019 May 16; 21(7):30. View Clinical Aspects of Thickeners for Pediatric Gastroesophageal Reflux and Oropharyngeal Dysphagia. Abstract

  60. The Impact of the American Academy of Pediatrics Brief Resolved Unexplained Event Guidelines on Gastrointestinal Testing and Prescribing Practices. J Pediatr. 2019 08; 211:112-119.e4. View The Impact of the American Academy of Pediatrics Brief Resolved Unexplained Event Guidelines on Gastrointestinal Testing and Prescribing Practices. Abstract

  61. Development of a Core Outcome Set for Infant Gastroesophageal Reflux Disease. J Pediatr Gastroenterol Nutr. 2019 05; 68(5):655-661. View Development of a Core Outcome Set for Infant Gastroesophageal Reflux Disease. Abstract

  62. Size and Prevalence of Pediatric Aerodigestive Programs in 2017. J Pediatr Gastroenterol Nutr. 2019 05; 68(5):e72-e76. View Size and Prevalence of Pediatric Aerodigestive Programs in 2017. Abstract

  63. Gastrointestinal Dysmotility and the Implications for Respiratory Disease. Curr Treat Options Pediatr. 2019 Jun; 5(2):197-214. View Gastrointestinal Dysmotility and the Implications for Respiratory Disease. Abstract

  64. Feeding Interventions Are Associated With Improved Outcomes in Children With Laryngeal Penetration. J Pediatr Gastroenterol Nutr. 2019 02; 68(2):218-224. View Feeding Interventions Are Associated With Improved Outcomes in Children With Laryngeal Penetration. Abstract

  65. Association of Proton Pump Inhibitors With Hospitalization Risk in Children With Oropharyngeal Dysphagia. JAMA Otolaryngol Head Neck Surg. 2018 12 01; 144(12):1116-1124. View Association of Proton Pump Inhibitors With Hospitalization Risk in Children With Oropharyngeal Dysphagia. Abstract

  66. A Distinct Esophageal mRNA Pattern Identifies Eosinophilic Esophagitis Patients With Food Impactions. Front Immunol. 2018; 9:2059. View A Distinct Esophageal mRNA Pattern Identifies Eosinophilic Esophagitis Patients With Food Impactions. Abstract

  67. Respiratory symptoms associated with eosinophilic esophagitis. Pediatr Pulmonol. 2018 11; 53(11):1587-1591. View Respiratory symptoms associated with eosinophilic esophagitis. Abstract

  68. Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference. Gastroenterology. 2018 10; 155(4):1022-1033.e10. View Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference. Abstract

  69. Proton Pump Inhibitor Use and Outcomes in Children With Respiratory Symptoms. JAMA Otolaryngol Head Neck Surg. 2018 07 01; 144(7):555-556. View Proton Pump Inhibitor Use and Outcomes in Children With Respiratory Symptoms. Abstract

  70. Presenting Signs and Symptoms do not Predict Aspiration Risk in Children. J Pediatr. 2018 10; 201:141-146. View Presenting Signs and Symptoms do not Predict Aspiration Risk in Children. Abstract

  71. Preoperative Evaluation Is Not Predictive of Transpyloric Feeding Conversion in Gastrostomy-dependent Pediatric Patients. J Pediatr Gastroenterol Nutr. 2018 Jun; 66(6):887-892. View Preoperative Evaluation Is Not Predictive of Transpyloric Feeding Conversion in Gastrostomy-dependent Pediatric Patients. Abstract

  72. Pediatric Gastroesophageal Reflux Clinical Practice Guidelines: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2018 03; 66(3):516-554. View Pediatric Gastroesophageal Reflux Clinical Practice Guidelines: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. Abstract

  73. The Case for Thoughtful Prescribing of Proton Pump Inhibitors in Infants. J Pediatr Gastroenterol Nutr. 2018 01; 66(1):e26-e27. View The Case for Thoughtful Prescribing of Proton Pump Inhibitors in Infants. Abstract

  74. Novel Pressure-Impedance Parameters for Evaluating Esophageal Function in Pediatric Achalasia. J Pediatr Gastroenterol Nutr. 2018 01; 66(1):37-42. View Novel Pressure-Impedance Parameters for Evaluating Esophageal Function in Pediatric Achalasia. Abstract

  75. How to Care for Patients with EA-TEF: The Known and the Unknown. Curr Gastroenterol Rep. 2017 Nov 25; 19(12):65. View How to Care for Patients with EA-TEF: The Known and the Unknown. Abstract

  76. Oropharyngeal Dysphagia Is Strongly Correlated With Apparent Life-Threatening Events. J Pediatr Gastroenterol Nutr. 2017 08; 65(2):168-172. View Oropharyngeal Dysphagia Is Strongly Correlated With Apparent Life-Threatening Events. Abstract

  77. The Prevalence of Rome IV Nonerosive Esophageal Phenotypes in Children. J Pediatr. 2017 10; 189:86-91. View The Prevalence of Rome IV Nonerosive Esophageal Phenotypes in Children. Abstract

  78. Feeding Problems and Their Underlying Mechanisms in the Esophageal Atresia-Tracheoesophageal Fistula Patient. Front Pediatr. 2017; 5:127. View Feeding Problems and Their Underlying Mechanisms in the Esophageal Atresia-Tracheoesophageal Fistula Patient. Abstract

  79. Impact of gastroesophageal reflux and delayed gastric emptying on pediatric lung transplant outcomes. J Heart Lung Transplant. 2017 Aug; 36(8):854-861. View Impact of gastroesophageal reflux and delayed gastric emptying on pediatric lung transplant outcomes. Abstract

  80. The Edematous and Erythematous Airway Does Not Denote Pathologic Gastroesophageal Reflux. J Pediatr. 2017 04; 183:127-131. View The Edematous and Erythematous Airway Does Not Denote Pathologic Gastroesophageal Reflux. Abstract

  81. ESPGHAN-NASPGHAN Guidelines for the Evaluation and Treatment of Gastrointestinal and Nutritional Complications in Children With Esophageal Atresia-Tracheoesophageal Fistula. J Pediatr Gastroenterol Nutr. 2016 11; 63(5):550-570. View ESPGHAN-NASPGHAN Guidelines for the Evaluation and Treatment of Gastrointestinal and Nutritional Complications in Children With Esophageal Atresia-Tracheoesophageal Fistula. Abstract

  82. Gastroesophageal Reflux Burden, Even in Children That Aspirate, Does Not Increase Pediatric Hospitalization. J Pediatr Gastroenterol Nutr. 2016 08; 63(2):210-7. View Gastroesophageal Reflux Burden, Even in Children That Aspirate, Does Not Increase Pediatric Hospitalization. Abstract

  83. Salivary Pepsin Lacks Sensitivity as a Diagnostic Tool to Evaluate Extraesophageal Reflux Disease. J Pediatr. 2016 10; 177:53-58. View Salivary Pepsin Lacks Sensitivity as a Diagnostic Tool to Evaluate Extraesophageal Reflux Disease. Abstract

  84. Airway reflux. Ann N Y Acad Sci. 2016 10; 1381(1):5-13. View Airway reflux. Abstract

  85. Symptom Association: An Imperfect Pairing. J Pediatr Gastroenterol Nutr. 2016 Apr; 62(4):517-8. View Symptom Association: An Imperfect Pairing. Abstract

  86. Acid Rather Than Nonacid Reflux Burden Is a Predictor of Tooth Erosion. J Pediatr Gastroenterol Nutr. 2016 Feb; 62(2):309-13. View Acid Rather Than Nonacid Reflux Burden Is a Predictor of Tooth Erosion. Abstract

  87. Oral Feeding Reduces Hospitalizations Compared with Gastrostomy Feeding in Infants and Children Who Aspirate. J Pediatr. 2016 Mar; 170:79-84. View Oral Feeding Reduces Hospitalizations Compared with Gastrostomy Feeding in Infants and Children Who Aspirate. Abstract

  88. Feeding Difficulties in Children with Esophageal Atresia. Paediatr Respir Rev. 2016 Jun; 19:21-7. View Feeding Difficulties in Children with Esophageal Atresia. Abstract

  89. 16S community profiling identifies proton pump inhibitor related differences in gastric, lung, and oropharyngeal microflora. J Pediatr. 2015 Apr; 166(4):917-23. View 16S community profiling identifies proton pump inhibitor related differences in gastric, lung, and oropharyngeal microflora. Abstract

  90. Changes in gastric and lung microflora with acid suppression: acid suppression and bacterial growth. JAMA Pediatr. 2014 Oct; 168(10):932-7. View Changes in gastric and lung microflora with acid suppression: acid suppression and bacterial growth. Abstract

  91. The sensitivity of acoustic cough recording relative to intraesophageal pressure recording and patient report during reflux testing. Neurogastroenterol Motil. 2014 Nov; 26(11):1635-41. View The sensitivity of acoustic cough recording relative to intraesophageal pressure recording and patient report during reflux testing. Abstract

  92. Gastroesophageal reflux in infants: more than just a pHenomenon. JAMA Pediatr. 2014 Jan; 168(1):83-9. View Gastroesophageal reflux in infants: more than just a pHenomenon. Abstract

  93. Intraesophageal pressure recording improves the detection of cough during multichannel intraluminal impedance testing in children. J Pediatr Gastroenterol Nutr. 2014 Jan; 58(1):22-6. View Intraesophageal pressure recording improves the detection of cough during multichannel intraluminal impedance testing in children. Abstract

  94. The utility of endoscopy and multichannel intraluminal impedance testing in children with cough and wheezing. Pediatr Pulmonol. 2014 Nov; 49(11):1090-6. View The utility of endoscopy and multichannel intraluminal impedance testing in children with cough and wheezing. Abstract

  95. Endoscopic intrapyloric injection of botulinum toxin A in the treatment of children with gastroparesis: a retrospective, open-label study. Gastrointest Endosc. 2012 Feb; 75(2):302-9. View Endoscopic intrapyloric injection of botulinum toxin A in the treatment of children with gastroparesis: a retrospective, open-label study. Abstract

  96. The impact of reflux burden on Pseudomonas positivity in children with cystic fibrosis. Pediatr Pulmonol. 2012 Jun; 47(6):582-7. View The impact of reflux burden on Pseudomonas positivity in children with cystic fibrosis. Abstract

  97. The presence of pepsin in the lung and its relationship to pathologic gastro-esophageal reflux. Neurogastroenterol Motil. 2012 Feb; 24(2):129-33, e84-5. View The presence of pepsin in the lung and its relationship to pathologic gastro-esophageal reflux. Abstract

  98. Anorectal manometry may identify children with spinal cord lesions. J Pediatr Gastroenterol Nutr. 2011 Nov; 53(5):507-11. View Anorectal manometry may identify children with spinal cord lesions. Abstract

  99. Interobserver and intraobserver variability in pH-impedance analysis between 10 experts and automated analysis. J Pediatr. 2012 Mar; 160(3):441-446.e1. View Interobserver and intraobserver variability in pH-impedance analysis between 10 experts and automated analysis. Abstract

  100. Higher rate of bronchoalveolar lavage culture positivity in children with nonacid reflux and respiratory disorders. J Pediatr. 2011 Sep; 159(3):504-6. View Higher rate of bronchoalveolar lavage culture positivity in children with nonacid reflux and respiratory disorders. Abstract

  101. Incidence of gastroesophageal reflux during transpyloric feeds. J Pediatr Gastroenterol Nutr. 2011 May; 52(5):532-5. View Incidence of gastroesophageal reflux during transpyloric feeds. Abstract

  102. Does reflux monitoring with multichannel intraluminal impedance change clinical decision making? J Pediatr Gastroenterol Nutr. 2011 Apr; 52(4):404-7. View Does reflux monitoring with multichannel intraluminal impedance change clinical decision making? Abstract

  103. Effect of different pH criteria on dual-sensor pH monitoring in the evaluation of supraesophageal gastric reflux in children. J Pediatr Gastroenterol Nutr. 2011 Apr; 52(4):399-403. View Effect of different pH criteria on dual-sensor pH monitoring in the evaluation of supraesophageal gastric reflux in children. Abstract

  104. Esophageal impedance monitoring for gastroesophageal reflux. J Pediatr Gastroenterol Nutr. 2011 Feb; 52(2):129-39. View Esophageal impedance monitoring for gastroesophageal reflux. Abstract

  105. Reflux events detected by pH-MII do not determine fundoplication outcome. J Pediatr Gastroenterol Nutr. 2010 Mar; 50(3):251-5. View Reflux events detected by pH-MII do not determine fundoplication outcome. Abstract

  106. Esophageal dysmotility in children with eosinophilic esophagitis: a study using prolonged esophageal manometry. Am J Gastroenterol. 2009 Dec; 104(12):3050-7. View Esophageal dysmotility in children with eosinophilic esophagitis: a study using prolonged esophageal manometry. Abstract

  107. Endoscopic repair of laryngeal cleft type I and type II: when and why? Laryngoscope. 2009 Sep; 119(9):1797-802. View Endoscopic repair of laryngeal cleft type I and type II: when and why? Abstract

  108. Role of acid and nonacid reflux in children with eosinophilic esophagitis compared with patients with gastroesophageal reflux and control patients. J Pediatr Gastroenterol Nutr. 2008 May; 46(5):520-3. View Role of acid and nonacid reflux in children with eosinophilic esophagitis compared with patients with gastroesophageal reflux and control patients. Abstract

  109. Lipid-laden macrophage index is not an indicator of gastroesophageal reflux-related respiratory disease in children. Pediatrics. 2008 Apr; 121(4):e879-84. View Lipid-laden macrophage index is not an indicator of gastroesophageal reflux-related respiratory disease in children. Abstract

  110. Esophageal dysmotility in patients who have eosinophilic esophagitis. Gastrointest Endosc Clin N Am. 2008 Jan; 18(1):73-89; ix. View Esophageal dysmotility in patients who have eosinophilic esophagitis. Abstract

  111. The sensitivity of multichannel intraluminal impedance and the pH probe in the evaluation of gastroesophageal reflux in children. Clin Gastroenterol Hepatol. 2006 Feb; 4(2):167-72. View The sensitivity of multichannel intraluminal impedance and the pH probe in the evaluation of gastroesophageal reflux in children. Abstract

  112. Use of multi-channel intraluminal impedance (MII) in the evaluation of children with respiratory symptoms: a new phenomenon? J Pediatr Gastroenterol Nutr. 2005 Aug; 41(2):166-8. View Use of multi-channel intraluminal impedance (MII) in the evaluation of children with respiratory symptoms: a new phenomenon? Abstract

  113. The importance of multichannel intraluminal impedance in the evaluation of children with persistent respiratory symptoms. Am J Gastroenterol. 2004 Dec; 99(12):2452-8. View The importance of multichannel intraluminal impedance in the evaluation of children with persistent respiratory symptoms. Abstract

  114. Incidence of spinal cord lesions in patients with intractable constipation. J Pediatr. 2004 Sep; 145(3):409-11. View Incidence of spinal cord lesions in patients with intractable constipation. Abstract

  115. Impeding gastroesophageal refluxate: a new application of an old medication. Gastroenterology. 2003 Sep; 125(3):984-5; discussion 985-6. View Impeding gastroesophageal refluxate: a new application of an old medication. Abstract

  116. Severe pancytopenia from thiopurine methyltransferase deficiency: a preventable complication of 6-mercaptopurine therapy in children with Crohn disease. J Pediatr Gastroenterol Nutr. 2002 Nov; 35(5):695-9. View Severe pancytopenia from thiopurine methyltransferase deficiency: a preventable complication of 6-mercaptopurine therapy in children with Crohn disease. Abstract

BESbswy